Details for New Drug Application (NDA): 072420
NDA 072420 describes AMOXAPINE, which is a drug marketed by Chartwell Rx, Watson Labs, and Watson Pharms Teva, and is included in six NDAs. It is available from two suppliers. Additional details are available on the AMOXAPINE profile page.
The generic ingredient in AMOXAPINE is amoxapine. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the amoxapine profile page.
The generic ingredient in AMOXAPINE is amoxapine. There is one drug master file entry for this compound. Two suppliers are listed for this compound. Additional details are available on the amoxapine profile page.
Summary for 072420
| Tradename: | AMOXAPINE |
| Applicant: | Watson Pharms Teva |
| Ingredient: | amoxapine |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 072420
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 100MG | ||||
| Approval Date: | May 11, 1989 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
